Jun Liu
MBBS, MSc, PhD
NOVO NORDISK RESEARCH FELLOW
After completing my clinical medicine degree at Shanghai Jiao Tong University in China in 2013, I gained experience in the clinical epidemiology of type 2 diabetes through a one-year research placement at Rui-Jin Hospital's Department of Endocrine and Metabolic Diseases in Shanghai. I then advanced my education with an MSc in genetic epidemiology from the Erasmus Medical Center in Rotterdam, Netherlands. My academic journey continued, culminating in a PhD with my thesis on "Integration of Multi-Omics in Type 2 Diabetes and Related Disorders Research."
In 2019, I relocated to Oxford to join the Nuffield Department of Population Health at the University of Oxford as a postdoctoral researcher, focusing on multi-omics data integration for cardiometabolic and neurological disorders.
Starting September 2021, I have been honored to work as a Novo Nordisk Research Fellow alongside Professor Cornelia van Duijn (NDPH) and Dr Joanna Howson (Novo Nordisk Research Centre Oxford). The project, "An Integrative Cross-omics Study of Non-Alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis," has led me to explore omics profiles and identify potential drug targets for NAFLD using proteomics, alongside integrating additional omics data.
In 2023, I achieved full registration with the General Medical Council (GMC) in the UK.
Key publications
-
Journal article
Liu J. et al, (2020), Nat Med, 26, 110 - 117
-
Journal article
Liu J. et al, (2019), Nat Commun, 10
-
Journal article
Liu J. et al, (2017), Diabetes, 66, 2915 - 2926
Recent publications
-
Journal article
Karjalainen MK. et al, (2024), Nature
-
Journal article
Liu J. et al, (2023), medRxiv
-
Journal article
Srinivasan S. et al, (2023), J Endocr Soc, 7
-
Journal article
Lin Y. et al, (2023), J Clin Endocrinol Metab
-
Journal article
Bonnechère B. et al, (2023), Alzheimer's & Dementia, 19